Last reviewed · How we verify
NCT06210412
The Effect of Health Education and Yoga on Menopause Symptoms and Quality of Life According to Pender's Model
NA trial testing health education and yoga intervention group in Quality of Life in 66 participants. Status unknown.
15 June 2024
Quick facts
| Lead sponsor | Eastern Mediterranean University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 66 |
| Start date | 1 March 2024 |
| Primary completion | 15 June 2024 |
| Estimated completion | 15 June 2024 |
| Sites | 1 location across Cyprus |
Drugs / interventions tested
- health education and yoga intervention group
Conditions studied
- Quality of Life — all drugs for Quality of Life →
- Health Education — all drugs for Health Education →
- Yoga — all drugs for Yoga →
- Menopause Symptoms — all drugs for Menopause Symptoms →
Sponsor
Eastern Mediterranean University
Who can join
Adults 45 to 65, female only, with Quality of Life or Health Education. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to examine the effect of health education and yoga intervention prepared according to Pender's Health Promotion Model on menopausal women's "menopause-specific quality of life" compared to routine care. Health education and yoga will be conducted by a certified and responsible investigator. After obtaining informed consent from the participants, the scales will be applied before and after health education and yoga practice.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06210412
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Quality of Life
Currently open trials in the same condition.
- NCT07498959 — Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer · NA · recruiting
- NCT07416448 — Neuroma-Associated Pain Management After Combat-Related Trauma in Ukraine · NA · recruiting
- NCT07412379 — Predictive Factors for Functional and Quality of Life Decline in Patients >65 Years With a Gastrointestinal Tract Cancer · recruiting
- NCT07380789 — Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in Ukraine · NA · recruiting
- NCT07280416 — Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer · recruiting
Other Eastern Mediterranean University trials
Trials by the same sponsor.
- NCT07462039 — Effect of Virtual Reality on Pain and Anxiety During Pap Smear Testing · NA · not yet recruiting
- NCT07328750 — Dynamic Q Angle and Core Endurance in Adolescent Athletes With Patellofemoral Pain Syndrome · recruiting
- NCT07311005 — NURSE - LED DIGITAL EDUCATION AND BIGOREXIA · NA · enrolling by invitation
- NCT07077993 — "Muscle Strength, Balance, and Core Endurance in Elite Adolescent Rowers: A Cross-Sectional Study" · completed
- NCT06953037 — Effects of Acupressure Applied Before Cesarean Delivery on Anxiety, Physiological Parameters and Fetal Heart Rate · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06210412 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eastern Mediterranean University
- Last refreshed: 18 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06210412.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing